sponsored
PatientsVille.com Logo

PatientsVille

Abilify and Ativan

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectAbilifyAtivan
WEIGHT INCREASED3.9% 1%
OFF LABEL USE3.8% 1.3%
NAUSEA1.7% 3.6%
FATIGUE1.8% 3.2%
DRUG INEFFECTIVE3% 2.6%
DIARRHOEA0.8% 2.6%
ANXIETY2.4% 2.4%
DYSPNOEA1% 2.4%
VOMITING1.3% 2.3%
HEADACHE1.4% 2.2%
DEPRESSION2.1% 1.7%
DIZZINESS1.5% 2.1%
PAIN1.3% 2.1%
INSOMNIA2% 1.7%
SUICIDAL IDEATION2% 0.8%
ASTHENIA0.8% 1.9%
TREMOR1.8% 1.1%
FALL1% 1.7%
SUICIDE ATTEMPT1.7% 0.7%
DEATH0.9% 1.6%
TARDIVE DYSKINESIA1.6% 0%
SOMNOLENCE1.5% 1.3%
PYREXIA0.7% 1.5%
DIABETES MELLITUS1.5% 0.6%
PNEUMONIA0.6% 1.5%
PSYCHOTIC DISORDER1.5% 0%
PRODUCT USE IN UNAPPROVED INDICATION1.5% 0%
DRUG INTERACTION1.4% 1.2%
MALAISE1.1% 1.4%
CONFUSIONAL STATE1% 1.3%
CONDITION AGGRAVATED1.3% 0.9%
WEIGHT DECREASED0.8% 1.3%
AKATHISIA1.3% 0%
AGITATION1.2% 0.9%
RASH0.7% 1.2%
CONSTIPATION0.6% 1.2%
HYPOTENSION0.5% 1.2%
ABDOMINAL PAIN0% 1.2%
FEELING ABNORMAL1.1% 1%
DECREASED APPETITE0.5% 1.1%
PAIN IN EXTREMITY0.5% 1.1%
ARTHRALGIA0.5% 1.1%
GAMBLING DISORDER1.1% 0%
MATERNAL EXPOSURE DURING PREGNANCY1.1% 0%
DYSKINESIA1.1% 0%
BACK PAIN0% 1.1%
DEHYDRATION0% 1.1%
HYPERTENSION0.7% 1%
COMPLETED SUICIDE0.6% 1%
CHEST PAIN0.6% 1%
INJURY1% 0.5%
AGGRESSION1% 0.5%
ANAEMIA0% 1%
OBSESSIVE-COMPULSIVE DISORDER1% 0%
TYPE 2 DIABETES MELLITUS1% 0%
RESTLESSNESS1% 0%
OVERDOSE0.8% 0.9%
DRUG DOSE OMISSION0.9% 0.6%
EXTRAPYRAMIDAL DISORDER0.9% 0%
MANIA0.9% 0%
COUGH0% 0.9%
MENTAL DISORDER0.9% 0%
EMOTIONAL DISTRESS0.9% 0%
ECONOMIC PROBLEM0.9% 0%
GAIT DISTURBANCE0.7% 0.8%
TOXICITY TO VARIOUS AGENTS0.5% 0.8%
HALLUCINATION0.8% 0.5%
ABDOMINAL PAIN UPPER0% 0.8%
TREATMENT NONCOMPLIANCE0.8% 0%
URINARY TRACT INFECTION0% 0.8%
ABNORMAL BEHAVIOUR0.8% 0%
ADVERSE EVENT0.8% 0%
PRURITUS0% 0.8%
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS0.8% 0%
NEUROLEPTIC MALIGNANT SYNDROME0.8% 0%
HOSPITALISATION0.8% 0%
MUSCLE SPASMS0.7% 0.7%
HYPERHIDROSIS0.6% 0.7%
LOSS OF CONSCIOUSNESS0.6% 0.7%
VISION BLURRED0.7% 0.6%
BLOOD GLUCOSE INCREASED0.7% 0.5%
TACHYCARDIA0.5% 0.7%
OEDEMA PERIPHERAL0% 0.7%
PARAESTHESIA0% 0.7%
HYPOAESTHESIA0% 0.7%
DELUSION0.7% 0%
BLOOD PRESSURE INCREASED0% 0.7%
FOETAL EXPOSURE DURING PREGNANCY0.7% 0%
ALOPECIA0% 0.7%
INTENTIONAL OVERDOSE0.7% 0%
SCHIZOPHRENIA0.7% 0%
DISABILITY0.7% 0%
DYSTONIA0.7% 0%
DYSPHAGIA0.6% 0.6%
MEMORY IMPAIRMENT0.6% 0.6%
PULMONARY EMBOLISM0.5% 0.6%
CONVULSION0.5% 0.6%
NEUTROPENIA0% 0.6%
MYOCARDIAL INFARCTION0% 0.6%
SEPSIS0% 0.6%
HAEMOGLOBIN DECREASED0% 0.6%
PALPITATIONS0% 0.6%
MYALGIA0% 0.6%
DRUG ABUSE0% 0.6%
RENAL FAILURE0% 0.6%
CEREBROVASCULAR ACCIDENT0% 0.6%
HALLUCINATION, AUDITORY0.6% 0%
COMPULSIVE SHOPPING0.6% 0%
WRONG TECHNIQUE IN DRUG USAGE PROCESS0.6% 0%
SEDATION0.6% 0%
PRODUCT USE ISSUE0.6% 0%
BLOOD CHOLESTEROL INCREASED0.6% 0%
IRRITABILITY0.6% 0%
OBESITY0.6% 0%
ATRIAL FIBRILLATION0% 0.5%
PLEURAL EFFUSION0% 0.5%
HEART RATE INCREASED0% 0.5%
MUSCULAR WEAKNESS0% 0.5%
CARDIAC ARREST0% 0.5%
PANCREATITIS0.5% 0%
DRUG WITHDRAWAL SYNDROME0% 0.5%
NEUROPATHY PERIPHERAL0% 0.5%
ERYTHEMA0% 0.5%
DRUG HYPERSENSITIVITY0% 0.5%
DEEP VEIN THROMBOSIS0% 0.5%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.5%
HYPONATRAEMIA0% 0.5%
SYNCOPE0% 0.5%
DISEASE PROGRESSION0% 0.5%
CHILLS0% 0.5%
THROMBOCYTOPENIA0% 0.5%
WHITE BLOOD CELL COUNT DECREASED0% 0.5%
EATING DISORDER0.5% 0%
RESPIRATORY FAILURE0% 0.5%
PLATELET COUNT DECREASED0% 0.5%
ABDOMINAL DISCOMFORT0% 0.5%
MUSCULOSKELETAL STIFFNESS0.5% 0%
PARKINSONISM0.5% 0%
BLOOD CREATINE PHOSPHOKINASE INCREASED0.5% 0%
SEIZURE0.5% 0%
ELECTROCARDIOGRAM QT PROLONGED0.5% 0%
DISTURBANCE IN ATTENTION0.5% 0%
CONTUSION0% 0.5%

New treatments are found every day. View current Abilify research studies and Ativan clinical trials

1